# ANDERA PARTNERS: Form 13F holdings

An institutional investment manager in PARIS. SEC CIK 1757283.

- Quarter ended: 2026-06-30
- Filed: 2026-07-22
- Reported value: $206.5m
- Positions: 8 (8 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1757283/000175728326000015/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| KESTRA MED TECHNOLOGIES LTD | SHS | $69.4m | 33.6% | 2,728,679 |  | Added +33,487 |
| [MINERALYS THERAPEUTICS INC (MLYS)](/companies/mlys.md) | COM | $42.9m | 20.8% | 1,591,917 |  | Unchanged |
| [AVALYN PHARMACEUTICALS INC (AVLN)](/companies/avln.md) | COM SHS | $30.6m | 14.8% | 929,824 |  | New +929,824 |
| [AGOMAB THERAPEUTICS NV (AGMB)](/companies/agmb.md) | SPONSORED ADS | $20.0m | 9.7% | 1,538,702 |  | Unchanged |
| [EVOMMUNE INC (EVMN)](/companies/evmn.md) | COM SHS | $18.5m | 9.0% | 1,391,990 |  | Reduced −505,372 |
| [INVENTIVA SA (IVA)](/companies/iva.md) | ADS | $13.7m | 6.7% | 3,633,181 |  | Added +1,815,000 |
| [ABIVAX SA (ABVX)](/companies/abvx.md) | SPONSORED ADS | $10.4m | 5.0% | 78,125 |  | Unchanged |
| NYXOAH S A | SHS | $882.3k | 0.4% | 522,057 |  | Unchanged |

Source: SEC EDGAR, Form 13F-HR, accession 0001757283-26-000015. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.